QINLOCK 50 mg tablets

DRUG3 trials

Sponsors

Deciphera Pharmaceuticals Inc.

Conditions

Advanced Gastrointestinal Stromal TumorAdvanced gastrointestinal stromal tumor (GIST)Patients with Advanced Gastrointestinal Stromal Tumors

Phase 1

A Master Protocol for the Multi-Cohort, Phase 1/2 Study of DCC-3116 in Combination With Anticancer Therapies in Participants With Advanced Malignancies

Not yet recruitingCTIS2024-516476-15-00

Deciphera Pharmaceuticals Inc.Advanced gastrointestinal stromal tumor (GIST)

Target: 87Updated: 2026-01-16

Phase 3

An International, Phase 3, Randomized, Multicenter, Open-label Study of Ripretinib vs Sunitinib in Patients with Advanced Gastrointestinal Stromal Tumor (GIST) with KIT Exon 11 and Co-occurring KIT Exons 17 and/or 18 Mutations Who Were Previously Treated with Imatinib (INSIGHT)

RecruitingCTIS2022-503058-37-00

Deciphera Pharmaceuticals Inc.Advanced Gastrointestinal Stromal Tumor

Start: 2023-11-10Target: 30Updated: 2025-07-14

A Phase 3, Interventional, Randomized, Multicenter, Open-Label Study of DCC-2618 vs Sunitinib in Patients with Advanced Gastrointestinal Stromal Tumors after Treatment with Imatinib

Active, not recruitingCTIS2024-513277-52-00

Deciphera Pharmaceuticals Inc.Patients with Advanced Gastrointestinal Stromal Tumors

Start: 2019-05-20Target: 144Updated: 2025-12-01